Press Releases

A Mighty product gives hope to Asthma sufferers

26-Mar-07

A unique, new product which has been developed in the UK has been launched to help the increasing numbers of people suffering with Asthma and other respiratory allergies. The scientifically and clinically proven Dust Mite Controller is available from Tower Health, a leading provider of innovative health products in the UK. It has been developed to tackle the growing problems caused by the miniscule dust mite.

A unique, new product which has been developed in the UK has been launched to help the increasing numbers of people suffering with Asthma and other respiratory allergies. The scientifically and clinically proven Dust Mite Controller is available from Tower Health, a leading provider of innovative health products in the UK. It has been developed to tackle the growing problems caused by the miniscule dust mite.

It is a staggering fact that 1 in 3 of the UK population are affected by allergies at some point in their lives - many of these directly attributed to the dust mite. In fact 5.2 million of the population are asthma suffers whilst over 15% of the population are thought to suffer hayfever which includes perennial rhinitis. Unlike pollen which is one of the causes of hayfever, dust mites are present all year round causing constant allergy 'perennial' allergic rhinitis.

These symptoms are a major problem for parents, as an increasing number of children are affected by the dust mite. In fact, figures show that 1 in 3 children are in some way allergic to the dust mite allergens. In addition, the dust mite can also be responsible for infantile eczema.

The traditional way to reduce the dust mite has been through hours and hours of hard work - every week. This can involve vacuuming, cleaning, washing and scrubbing which apart from being tedious, time-consuming and dull, still inevitably leaves the mite to thrive.

The Dust Mite Controller couldn't involve less hard work! Simply plug it in and it does everything for you. The Dust Mite Controller is unique in the way it works - there is nothing like it in the World and it has the clinical and scientific evidence to support this. The device emits a range of ultrasonic sounds (not heard by humans or pets) when plugged in. These sounds interfere with the feeding and reproductive cycles of the dust mite, reducing the population of the dust mite and the allergens produced (faecal matter).

Commenting upon the new Dust Mite Controller Roger Bratton, Director at Tower Health said, "The Dust Mite Controller is a unique device which has been developed by a team of experts from the UK. It has been developed to answer the needs of the millions of allergy sufferers in the UK and around the globe who are affected by the tiny enemy - the dust mite. The clinical and scientific evidence demonstrates its effectiveness and already we have testimonials from many satisfied customers."

The Dust Mite Controller is a non toxic device, without any use of chemical substances. Priced at £49.95, the Dust Mite Controller is available from www.tower-health.co.uk or by calling 08450 066 077.

Comments

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Healthcare Republic Forums

 

Latest Clinical Articles

Stable angina pectoris

Section 1 Definition and pathophysiology Read more

Endometriosis

Contributed by Mr Michael Booker, consultant obstetrician & gynaecologist, and fertility specialist ... Read more

Primary hyperparathyroidism

Contributed by Mr David Scott-Coombes, consultant endocrine surgeon at the University Hospital of Wa... Read more

Show all clinical articles

Latest News

RCGP president urges doubling of GP consultation length

GP consultations should be twice as long if they are to meet patient needs, the president of the RCG... Read more

BMA explains why it gave up GP primary care monopoly

Allowing alternative providers into general practice was inevitable, BMA Council chairman Dr Hamish ... Read more

Correction factors to be cut from 1 October

Correction factors will be cut from 1 October, the GPC has announced. Read more

HIV patients live 13 years longer

Life expectancy for HIV patients is now 13 years longer than in the 1990s, say UK researchers. Read more

'Invest in school nurses to tackle obesity', says RCN

The government must invest in specialists and school nurses to put children on the right track to ta... Read more

MIMS Product News

Toviaz

New drug - Toviaz

Pfizer has launched Toviaz (fesoterodine), a once-daily treatment for the symptoms of overactive bla... Read more

New drug - Tasigna

Novartis has launched Tasigna (nilotinib), a new antineoplastic agent for Philadelphia chromosome po... Read more

Ciproxin licensed for UTI in children

The licence for Ciproxin (ciprofloxacin) has been extended to include the second- and third-line tr... Read more

Jobs

 

Job of the Week